Finance

Lists
ACIU:NASDAQ
AC Immune SA
$2.68
0.00%
(0.00) 1D
Sep 17, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ACIU...
Mkt. cap
272.75M
Avg. vol.
203.56K
Volume
21.00
52-wk high
$4.00
52-wk low
$2.10
EPS
-$0.52
Beta
1.60
Shares outstanding
101.77M
No. of employees
106
Mkt. cap
272.75M
Avg. vol.
203.56K
Volume
21.00
52-wk high
$4.00
52-wk low
$2.10
EPS
-$0.52
Beta
1.60
Shares outstanding
101.77M
No. of employees
106
News stories
From web sources and news partners
About AC Immune SA
CEOAndrea Pfeifer
Employees106
Founded2003
Headquarters-
SectorBiotechnology
Websiteacimmune.com
Analyst ratings
Based on 2 analysts giving stock ratings to ACIU in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for ACIU in the last 3 months.
Highest
Current $2.68
$12.00 (+347.76%)
Average
$10.00 (+273.13%)
Lowest
$8.00 (+198.51%)
Analyst
Recommendation
Action
Price target
Projected
Date
Andrew Fein
H.C. Wainwright
Buy
Reiterated
$12.00
+347.8%
08/24/2026
Thomas Shrader
BTIG
Buy
Maintained
$8.00
+198.5%
08/20/2026
Marc Goodman
Leerink Partners
Buy
Maintained
-
-
04/07/2026
Previous reportsAll values in CHF
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CHF
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
939.00K
338.00K
1.12M
15.11M
Cost of goods sold
13.07M
10.62M
11.74M
10.48M
Cost of revenue
13.07M
10.62M
11.74M
10.48M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.57M
4.19M
4.17M
3.54M
Operating expense
3.57M
4.12M
4.16M
3.44M
Total operating expenses
16.64M
14.74M
15.91M
13.92M
Operating income
-15.70M
-14.41M
-14.79M
1.19M
Other non operating income
-
-
-
-
EBT including unusual items
-15.86M
-14.37M
-14.80M
1.87M
EBT excluding unusual items
-15.39M
-14.38M
-14.80M
1.87M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-73.00K
-11.00K
-96.00K
Net income
-15.86M
-14.37M
-14.80M
1.87M
Net profit margin
-1,688.82%
-4,252.37%
-1,322.70%
12.40%
Earnings per share
-0.16
-0.14
-0.15
0.02
Interest and investment income
366.00K
353.00K
228.00K
171.00K
Interest expense
-46.00K
-42.00K
-65.00K
-61.00K
Net interest expenses
320.00K
311.00K
163.00K
110.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-15.36M
-14.08M
-14.44M
1.47M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps